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Abstract
Objectives: The aim of this phantom study was to minimize the radiation dose by finding the best combination of low tube
current and low voltage that would result in accurate volume measurements when compared to standard CT imaging
without significantly decreasing the sensitivity of detecting lung nodules both with and without the assistance of CAD.
Methods: An anthropomorphic chest phantom containing artificial solid and ground glass nodules (GGNs, 5–12 mm) was
examined with a 64-row multi-detector CT scanner with three tube currents of 100, 50 and 25 mAs in combination with
three tube voltages of 120, 100 and 80 kVp. This resulted in eight different protocols that were then compared to standard
CT sensitivity (100 mAs/120 kVp). For each protocol, at least 127 different nodules were scanned in 21–25 phantoms. The
nodules were analyzed in two separate sessions by three independent, blinded radiologists and computer-aided detection
(CAD) software.
Results: The mean sensitivity of the radiologists for identifying solid lung nodules on a standard CT was 89.7%64.9%. The
sensitivity was not significantly impaired when the tube and current voltage were lowered at the same time, except at the
lowest exposure level of 25 mAs/80 kVp [80.6%64.3% (p= 0.031)]. Compared to the standard CT, the sensitivity for
detecting GGNs was significantly lower at all dose levels when the voltage was 80 kVp; this result was independent of the
tube current. The CAD significantly increased the radiologists’ sensitivity for detecting solid nodules at all dose levels (5–
11%). No significant volume measurement errors (VMEs) were documented for the radiologists or the CAD software at any
dose level.
Conclusions: Our results suggest a CT protocol with 25 mAs and 100 kVp is optimal for detecting solid and ground glass
nodules in lung cancer screening. The use of CAD software is highly recommended at all dose levels.
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Introduction
Image noise in computed tomography (CT) is mainly caused by
photon statistics, also known as quantum noise. Photon starvation
and electronic noise become significant at low dose levels and with
obese patients. Tube current and voltage are two important user-
selectable parameters in CT imaging that can influence quantum
noise. With lower tube currents or voltage it is possible to reduce
the applied radiation dose to patients; however, this reduction will
also increase the quantum noise and will decrease the image
quality [1].
In the past, several studies have shown that it is possible to lower
the tube current, and therefore also lower the radiation dose, in
CT imaging without a major loss of objective or subjective image
quality [2–13]. To maintain diagnostic quality in the detection of
lung nodules, tube currents can be reduced to well below 100 mAs
at a constant voltage of 120 kVp [2,3,11]. Some authors proposed
reducing the current to 80, 70, 60 or even 10 mAs [4–12], which
corresponds to dose reductions of 50–84%. Some studies even
defined threshold tube currents of 20 mAs to detect ground glass
nodules (GGNs), alveolar consolidations and lung nodules [3,13].
Another approach to reducing the radiation dose in CT imaging is
to decrease the tube voltage. High voltages from 100–140 kVp are
still widely used; however, promising results suggest that a voltage
reduction to 80 kVp is possible [14–17]. There is very little data
on the combination of reduced kVp and mAs for lung nodule
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detection. Phantom studies are well suited for detecting the
threshold levels at which diagnostic accuracy is not altered and the
patient is not exposed to accessory radiation.
A low-dose protocol would not only protect the population
undergoing screening CT imaging for early lung cancer detection
but would also reduce the cumulative radiation dose of follow-up
CT exams in patients with suspected lung metastases, incidental
lung nodules, tuberculosis and pulmonary fungal infections.
The usefulness of computer-aided detection (CAD) software for
lung nodule detection has been published previously [19–23].
However, Lee et al. [23] showed that the sensitivity of a CAD
system (81%) did not significantly differ from the sensitivity of
radiologists (85%). Radiologists were better able to detect nodules
attached to other structures, whereas the CAD was better at
detecting isolated nodules and nodules that were #5 mm in
diameter [23].
Recently published articles have indicated that the combination
of radiologists and CAD could increase detectability between 2
and 14% [18–20]. Hein et al. described the feasibility of low-dose
CAD at 5 mAs and 120 kVp [24]; however, there have been few
reports on the accuracy of using low-dose CAD as a standalone
tool or in combination with radiologists.
Low-dose CT imaging has been criticized for its lack of
accuracy in nodule size measurement, which is critical for follow-
up examinations. One study showed no significant impact on
volume measurement with the CT dose [2], while another group
found that nodule volume was underestimated at lower doses [25].
The aim of this phantom study was to minimize the radiation dose
by finding the best combination of low tube current and low
voltage that would result in accurate volume measurements when
compared to standard CT imaging without significantly decreas-
ing the sensitivity of detecting lung nodules both with and without
the assistance of CAD.
Materials and Methods
Lung Phantom
A commercially available lung phantom (Chest Phantom N1,
Kyoto Kagaku Co., Ltd, Kyoto, Japan) was used (Fig. 1). This
anthropomorphic phantom is an accurate life-size anatomical
model of a male human torso with synthetic heart, trachea,
pulmonary vessels (right and left) and abdomen (diaphragm) block.
The thickness of the chest wall is based on clinical data
measurements. The x-ray absorption rates of the soft tissue
substitute material (polyurethane, gravity 1.06) and synthetic
bones (epoxy resin) are very similar to human tissue absorption
rates. The arms-abducted torso position was appropriate for CT
scanning. The pulmonary vessels are spatially traceable.
The phantom size was 43 cm640 cm648 cm (height), which
is based on an average Japanese male with a body weight of
70 Kg.
Image Acquisition
CT images of the chest phantom were obtained with a 64-row
multi-detector CT scanner Somatom Sensation 64 (2461.2 mm,
pitch 0.8, slice thickness 1.5 mm, increment 1.5 mm by Siemens,
Forchheim, Germany). The scan length and field of view were
kept identical at 35 cm and 33 cm, respectively. Three tube
currents of 100, 50 and 25 reference mAs were combined with
three tube voltages of 120, 100 and 80 kVp, which resulted in nine
different protocols (reference mAs/peak voltage): 100/120, 100/
100, 100/80, 50/120, 50/100, 50/80, 25/120, 25/100 and
25 mAs/80 kVp. The 100 ref mAs/120 kVp combination repre-
sents the standard image quality that is used routinely in Europe
[26,27]. The other eight kV/mAs combinations are referred to as
low-dose protocols. Automatic current modulation (CareDose4D)
was used to approximate the routine scans and to maintain
independence from body weight and body mass index (BMI).
Based on the image quality reference mAs, the scanner was able to
adapt the tube current for each scan position (effective mAs) and to
obtain the same specific image quality (reference mAs) over the
entire scan length based on the size of the patient. Images from the
Somatom Sensation were reconstructed using the classic filtered
back projection with a lung kernel of B60 for best diagnostic
accuracy and to meet the preset CAD. Dose was represented by
the dose length product DLP (mGycm) provided by the scanner.
Artificial Nodules
Four artificial solid nodules (+100 Hounsfield units [HU]; 5, 8,
10 and 12 mm) and 4 artificial GGNs (2630 HU; 5, 8, 10 and
12 mm) from KYOTO KAGAKUH (Kyoto, Japan) were used
(Fig. 1). To simulate a realistic cancer patient, 0 to 8 nodules were
placed in all lung segments; the number, location and size of the
nodules were chosen at random. To detect a significant drop (5%)
in sensitivity (estimate of 85% at the standard-dose CT) with a
statistical power of 80% at an alpha level of 0.05, 62 nodules per
kV/mAs combination were needed. To prevent recognition bias,
nodules were rearranged for each dose level: the phantom was
bilaterally filled with a random number of solid nodules and
GGNs until the number of nodules in both categories reached at
least 62. This process was repeated for each dose level. The lung
segment, side and size were also randomly assigned to each
nodule; therefore, the average nodule size should be the mean of
the four sizes (8.75 mm). The nodules were placed between 1 and
5 cm away from the chest wall to ensure the same diagnostic
difficulty. On average, 19 phantoms were needed. In addition, 4
normal phantom scans were added at each dose level. In total,
there were 127 to 143 solid nodules and GGNs at each dose level,
with a sum of 1209 nodules (579 solid and 630 GGN) for the nine
protocols.
Image Analysis
Three blinded radiologists with 5, 3 and 2 years of experience in
thoracic radiology separately read all CT datasets on a PACS
workstation (Picture Archiving and Communication System
R11.4.1, 2009; Philips, Best, Netherlands; Sectra, Linkoping,
Sweden). The radiologists were not part of the research group.
Each nodule was registered as ‘‘yes’’ or ‘‘no’’ by capturing the
nodule slice position, side and density (ground glass or solid).
Radiological workstations are not yet available at all institutions
worldwide for fast image reconstructions like maximum intensity
projection (MIP) or multiplanar reconstruction (MPR). Therefore,
radiologists were not allowed to use MIP or MPR for this study
and read the axial slices only. In addition, all radiologists scored
the subjective image quality on a linear scale from 1 to 5 in the
lung window (level 2500 HU, width 1500 HU) with hard Kernel
B60f. The subjective grading scale was as follows: 1 - non-
diagnostic image quality (0–20% subjective image quality); 2 -
poor, diagnostic confidence significantly reduced (21–40%); 3 -
moderate, but sufficient for diagnosis (41–60%); 4 - good (61–
80%); and 5– excellent (81–100%). Half-point classifications were
accepted. In a second reading session, all datasets were analyzed
by the CAD software as a standalone reader. CT images were sent
to a Median workstation (Median Technologies, Valbonne,
France), where the CAD software Lesion Management Solutions
LMS Version 6.0 (Median Technologies, Valbonne, France)
searched for the different nodules on 1.5-mm slices. According to
the manufacturer, the detection performance of LMS-CAD is
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optimized for solid pulmonary nodules but can also detect GGNs.
A fourth reader with 2 years of experience in thoracic radiology
analyzed the performance of the CAD by tracking the true-
positive and false-positive findings using an answer key that
detailed the nodule positions.
Reproducibility of Volume Measurements at Lower Dose
Levels
The impact of dose and attenuation on the measured size of
solid nodules was analyzed in all nodules at nine dose levels
(n = 579). The frequencies of the four nodule sizes of 5, 8, 10 and
12 mm should be the same after random assignment, with an
average nodule size of 8.75 mm. One reader (with 5 years of
experience in chest radiology) measured the longest axial diameter
of all nodules digitally (according to the Response Evaluation
Criteria In Solid Tumors; RECIST [28,29]) and calculated their
volumes by multiplying the longest axial axis, the perpendicular
short axial axis, the longest coronal z-axis and p/6 at all nine dose
levels. In a second round, the nodules were measured by the
Median workstation. The computer used segmentation and
threshold methods for automated volume and longest axial
diameter measurement. A fourth radiologist with 2 years of
experience in chest radiology performed this semi-automatic
process by clicking on the designated nodule. In addition, as a
standard of reference, the spherical volume was calculated by
measuring the real diameters in three dimensions with a
micrometer (p*d1*d2*d3)/6. With this process, absolute and
relative measurement errors could be stratified for the different
lesion sizes as relative error increases with a decrease in lesion size.
Statistics
Data from the three independent human readers were
averaged, and the mean and individual data were used for
statistical analysis. The practicability of data pooling was tested:
for each reader at each dose level the chi square test was applied to
the different nodule sizes (3 degrees of freedom) with p values
ranging from 0.18 to 0.77 indicating the validity of pooling the
different nodule sizes (null hypothesis of data homogeneity cannot
be rejected in favor of heterogeneity). A logistic regression proved
the feasibility of pooling the solid and the ground glass nodules
together with a p-value of 0.6 for nodule type (accepting
homogeneity). The sensitivities of all ground glass and solid
nodules were calculated at all dose levels. The known number of
nodules per scan was used as the standard of reference. In
addition, an analysis per nodule diameter and nodule type (solid or
GGN) was performed separately with all nodules on all dose levels.
Figure 1. Anthropomorphic chest phantom with artificial lung nodules at different dose levels. At the standard CT dose level of
100 mAs/120 kVp (a), the 10-mm ground glass nodule (GGN) is easily detectable. At the lowest exposure level of 25 mAs/80 kVp (c), the 10-mm GGN
is still visible, but the sensitivity is significantly impaired. The lowest acceptable dose level without a loss of sensitivity for detecting GGNs (12 mm)
was 25 mAs/100 kVp (b). For solid nodules, the decrease in detectability was less obvious from the standard dose with a 10-mm nodule (d) to the
lowest dose with an 8-mm nodule (f). However, for maintaining sensitivity, a dose of 25 mAs/100 kVp is necessary. (e), Example of a 10-mm nodule.
The phantom received only 22% of the standard CT dose (a, d) at the lowest acceptable exposure level (b, e).
doi:10.1371/journal.pone.0082919.g001
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Paired comparisons of the sensitivity at a specific dose level against
the normal dose dataset were performed for each nodule size and
nodule type. The null hypothesis of equality of sensitivity for each
dose pair was tested by applying the Z-test of proportions (Chi-
Square) [30]. The change in sensitivity for the combined sensitivity
(radiologist and CAD) compared to the sensitivity of the radiologist
alone was analyzed using McNemar’s test [31]. For the combined
sensitivity, a positive finding was defined as either the radiologist,
the CAD or both detected the nodule. To calculate the inter-
observer agreement, the detection of all true-positive nodules and
the classification into ground glass and solid nodules was taken into
account separately for each dose level. Radiologists were
compared among each other, and the agreement of each
radiologist and the CAD was calculated. Mean agreements for
the radiologists and the radiologists against CAD were deter-
mined. Inter-observer comparison was performed by calculating
agreement levels using Fleiss’ Kappa statistics [32,33]. The Kappa
strength of agreement was as follows: ,0.20 poor agreement,
0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good and 0.81–
1.00 very good [34]. Inter-observer agreement between ‘radiolo-
gist-radiologist’ and ‘radiologist-CAD’ was tested using the
comparison of correlation coefficients [30].
Confidence intervals were used to determine agreements of
volume measurements between known nodule sizes and the
displayed nodule sizes on standard and on all low-dose CTs (for
radiologist and the CAD measurements, respectively). The
confidence interval (CI) for the measurement difference of the
volume and the diameter gives the range of 95% of all volume
measurement errors (VMEs) and is calculated from the standard
deviation of the measurement differences [31]. To detect
significant differences in the volume measurements, the CI of
the VME should not include 0 for a significant systematic bias.
With an increase in nodule volume at a hypothetical nodule
follow-up of over the upper CI, the probability of real growth
would be 95%. The standard deviation of the diameter and
volume measurements of the nodules on the highest and lowest
dose CT was compared using the F-test to determine the
measurement variability. The Z-test was used to compare
subjective image quality. The Z-test, McNemar test, F-test, Fleiss’s
k statistics and the power analysis were performed using
MedCalcH Version 7.6.0.0 (MedCalc Software, Mariakerke,
Belgium).
Results
Between 127 and 143 solid nodules and GGNs were scanned at
each of the nine dose levels. In total, 1209 nodules (579 solid
nodules and 630 GGNs) were scanned. The average radiation
exposure at each dose level is given as the dose length product in
Table 1.
Nodule Detection by Human Observers Only
The average sensitivity for detecting solid nodules on a standard
CT was 89.7%64.9 (6standard deviation [SD]) and only dropped
significantly at the lowest dose level (25 mAs/80 kVp; sensitivity,
80.6%64.3 [p= 0.031]). The sensitivity for the individual readers
at each dose level is given in Appendix S1. The mean sensitivity of
detecting GGNs on a standard CT was 94.9%%64.4 and
dropped significantly at 80 kVp to 87.2%, 86.6% and 85.0% for
100, 50 and 25 mAs, respectively (p from 0.02 to 0.04).
Detectability was not impaired for dose levels that included 120
or 100 kVp (Fig. 1). The sensitivity for all nodules (solid nodules
and GGNs together) was 92.3%%64.1%, which also dropped
significantly at 80 kVp (Table 1).
Nodule Detection with CAD Only
At the standard dose level, CAD identified 91.4% (95% CI: 81.1
to 96.6%) of all solid nodules and only 59.1% (95% CI: 46.5 to
70.7%) of all GGNs. The sensitivity for solid nodule detection
dropped to 78.6% (95% CI: 65.9 to 87.6%) at the lowest dose
level, but this decrease was not significant. The capacity to detect
GGNs was already impaired at 50 mAs and dropped to 20.6%
(CI: 12.0 to 32.8%) at the lowest dose. Therefore, the total
sensitivity of detecting all solid nodules and GGNs was also
insufficient at 50 and 25 mAs with any kVp (Table 1). The average
false-positive rate for one phantom scan was 13.7 on a standard
CT and dropped to 4.9 at the lowest dose level.
Human Observers versus CAD Software
At the standard dose level, the radiologists were significantly
better than the CAD at detecting GGNs (94.9% and 59.1%,
respectively) (p,0.0001), whereas the CAD demonstrated a non-
significant higher average sensitivity for detecting solid nodules
(91.4%) compared to the radiologists (89.7%) (p= 0.087). More-
over, two of the radiologists had slightly better sensitivities than the
CAD, and one had a lower sensitivity (Appendix S1, p between
0.32 and 0.85). The results for the other dose levels are shown in
Table 1.
Inter-observer Variability
On average, the inter-observer agreement among the three
radiologists was 0.9060.08 (standard error [SE]) for standard CT
and only dropped significantly at the lowest dose level. The K
strength of agreement fell significantly to 0.8060.09 (p = 0.0029).
The agreement between CAD and the radiologists was lower: for
the standard CT, the mean agreement was 0.6960.11
(p,0.0001), whereas the mean agreement for the lowest dose
was 0.5260.13 (p,0.0001). The inter-dose variabilities for CAD
and radiologists are listed in Table 2.
Combined Sensitivities for the Radiologists and CAD
At the standard dose level, the sensitivity for detecting solid
nodules rose significantly by 5.1% to 94.8%62.4% (p= 0.021)
when the independent CAD data were combined with the
radiologists’ data. When the dose was lowered, the additional
sensitivity from CAD rose to a maximum of 11.1% for 25 mAs/
100 kVp (Fig. 2). Individual and dose-dependent additions to the
sensitivities varied from 0% to 16.7% (Appendix S1). There was
no increase in the sensitivity of detecting GGNs on the standard
CT, but at 100 mAs/100 kVp, the sensitivity increased by
4.2%68.4% (p= 0.25). For all dose levels, the sensitivity for all
nodules together rose significantly between 2.5% and 5.9% using
CAD (p,0.05). At the standard dose, the sensitivity for all nodules
increased significantly from 92.3% to 94.8%. With the exception
of the 25 mAs/80 kVp dose, for which the sensitivity dropped
significantly to 86.8%63.0%, the combined sensitivity remained
constant over all dose levels (Table 1).
Nodule Detection Per Diameter and Per Nodule Type
(Table 3)
The radiologists’ mean sensitivities for detecting solid nodules of
12, 10, 8 and 5 mm diameters at the standard CT dose were
90.2%65.3%, 90.6%68.8%, 95.1%63.9% and 84.8%610.5%,
respectively. The differences in detectability were not significant
(p.0.07). At the lowest dose level, the sensitivities dropped to
82.5%610.5%, 89.1%610.0%, 83.2%69.7% and 66.1610.9%,
respectively; however, the decrease in sensitivity was only
significant for the solid 5-mm nodule (p = 0.036). There were no
Optimal Dose Levels for Lung Cancer Screening CT
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other significant drops in sensitivity for any of the nodules when
the dose was decreased from the standard level. The mean
sensitivities of the radiologists for detecting GGNs of 12, 10, 8 and
5 mm diameter were 98.3%61.0%, 98.4%60%, 95%62.7% and
86.0%610.2%, respectively. These sensitivities decreased at the
lowest dose to 87.4%611.8%, 90.8%68.4%, 90.8%68.4% and
73.1%617.1%, respectively; however, the decreases were not
significant. The sensitivities of CAD as a standalone device were
similar for all solid nodules except at the lowest dose level
(Appendix S2). In contrast, when the dose was decreased for small
GGNs, the sensitivity decreased significantly. For example, the
CAD was not able to detect 5-mm GGNs at the lowest dose levels.
For the smallest solid nodules (5 mm), when the data from the
radiologists and the CAD were combined the sensitivity increased
significantly by 9.9–25.3% at all dose levels. For all of the other
nodules and dose levels, the sensitivity was not affected when the
CAD reading was added.
Table 1. Sensitivities of readers and CAD alone and combined for each exposure level.
Mean sensitivity of readers alone ± standard
deviation Sensitivity CAD
Tube parameters DLP tot solid ggn tot solid ggn
(mGycm)
100 mAs 120 kVp 183.8 92.3%±4.1% 89.7%±4.9% 94.9%±4.4% 74.9% 91.4% 59.1%
100 mAs 100 kVp 128.4 90.7%68.8% 89.0%67.9% 92.3%68.3% 75.4% 91.2% 60.2%
100 mAs 80 kVp 71 85.9%64.9%* 84.6%63.3% 87.2%69.7%* 74.0% 89.7% 58.9%
50 mAs 120 kVp 122.5 91.1%65.6% 88.4%66.1% 93.5%66.7% 60.5%* 93.3% 35.6%*
50 mAs 100 kVp 82.6 90.0%65.0% 89.9%67.6% 90.0%62.7% 60.0%* 90.3% 37.3%*
50 mAs 80 kVp 45.9 86.9%63.5%* 87.4%65.7% 86.6%64.6%* 55.3%* 82.2% 35.4%*
25 mAs 120 kVp 61.2 90.4%67.2% 88.2%68.3% 92.5%66.2% 54.1%* 88.1% 21.6%*
25 mAs 100 kVp 40.7 88.2%65.0% 86.6%65.2% 89.8%65.4% 61.6%* 86.1% 38.2%*
25 mAs 80 kVp 22.3 82.9%63.7%* 80.6%64.3%* 85.0%63.1%* 48.9%* 78.6% 20.6%*
Mean sensitivity of readers+CAD combined ± standard
deviation
CAD vs Radiologists
tot solid ggn tot solid ggn
100 mAs 120 kVp 94.8%±2.4% 94.8%±2.3% 94.9%±4.4% 74.9%** 91.4% 59.1%**
100 mAs 100 kVp 95.1%65.5% 93.6%65.4% 96.5%65.8% 75.4%** 91.2% 60.2%**
100 mAs 80 kVp 91.7%62.8% 93.3%62.8% 90.2%67.7% 74.0%** 89.7% 58.9%**
50 mAs 120 kVp 94.2%65.1% 95.1%63.2% 93.5%66.7% 60.5%** 93.3% 35.6%**
50 mAs 100 kVp 93.7%60.8% 96.6%61.3% 91.3%60.8% 60.0%** 90.3% 37.3%**
50 mAs 80 kVp 91.4%61.7% 96.3%62.0% 87.2%63.6% 55.3%** 82.2% 35.4%**
25 mAs 120 kVp 94.8%62.9% 96.1%61.3% 93.5%64.7% 54.1%** 88.1% 21.6%**
25 mAs 100 kVp 94.1%63.8% 97.7%62.5% 90.7%65.1% 61.6%** 86.1% 38.2%**
25 mAs 80 kVp 86.8%63.0%* 88.6%62.9%* 85.0%63.1%* 48.9%** 78.6% 20.6%**
Delta sensitivity of readers+CAD ± standard deviation
tot solid ggn
100 mAs 120 kVp 2.5%±1.7%* 5.1%±3.6%* 0.0%±0.0%
100 mAs 100 kVp 4.4%63.4%* 4.6%62.5%* 4.2%64.6%
100 mAs 80 kVp 5.8%62.1%* 8.7%63.2%* 3.0%62.6%
50 mAs 120 kVp 3.1%62.1%* 6.7%64.4%* 0.0%60.0%
50 mAs 100 kVp 3.8%64.2%* 6.7%66.7%* 1.3%62.2%
50 mAs 80 kVp 4.4%62.1%** 8.9%63.8%* 0.6%61.1%
25 mAs 120 kVp 4.4%64.6%** 7.9%67.7%* 1.0%61.6%
25 mAs 100 kVp 5.9%61.2%** 11.1%62.7%** 1.0%61.6%
25 mAs 80 kVp 3.9%60.7%* 7.9%61.4%* 0.0%60.0%
Note - DLP, dose length product, tot, total nodules (solid+ggn); solid, solid nodule; ggn, gound glass nodule; mAs, Miliampe`resecond; kVp, Kilovolt peek; CAD,
computer assisted detection.
*significant: p-value,0.05; compared to standard dose CT, to radiologists without CAD (delta) or CAD compared to radiologists (CAD vs Radiologists).
**significant: p-value,0.001; compared to standard dose CT, to radiologists without CAD (delta) or CAD compared to radiologists (CAD vs Radiologists).
doi:10.1371/journal.pone.0082919.t001
Optimal Dose Levels for Lung Cancer Screening CT
PLOS ONE | www.plosone.org 5 December 2013 | Volume 8 | Issue 12 | e82919
Subjective Image Quality
At the standard dose level, the median subjective score (on a
scale from 1 to 5) was 5 ( = 100%). This value dropped significantly
to 2.75 ( = 55%) at the lowest dose level (p,0.0001, Fig. 2).
Longest Diameter and Volume Measurements of Solid
Lung Nodules at the Standard and Reduced Doses
The mean longest diameter (according to the RECIST
guidelines [28,29]) of the 65 solid nodules at the standard CT
dose was 8.6 mm. The absolute measurement error of the
radiologist was an average of +0.10 mm60.32 mm (SD), with
an average relative measurement error of +1.5%64.7%; the errors
were not significant. The average volume of these nodules was
334.5 mm3. The radiologist overestimated the volume by an
average of 3.8 mm3631.8 mm3, with an average relative volume
measurement error of 3.8%611.7%; neither finding was signifi-
cant. Similar results were achieved at all dose levels. The
measurement error increased to +0.29 mm60.39 mm at the
lowest exposures; however, the error was not significant. The SD
of the volume measurement differences at the standard CT dose
(31.8 mm3) was significantly lower than the SD of the lowest dose
CT (47.6 mm3), indicating a higher variance in the measurement
differences at lower dose levels (p = 0.002). When the CAD was
used as a semi-automated diameter and volume measurement tool,
the measurement errors were +5.8%68.7% and +13.7%616.8%,
respectively. The measurement errors and the SD were greater at
lower dose levels; however, none of the errors was significantly
different from the true volume (Table 3). The average volumetry
errors of the radiologists and CAD at the lowest dose level
(25 mAs/80 kVp) were 21.3%610.4% and 28.0%615.6%,
respectively. In addition, at the second lowest dose level
(25 mAs/100 kVp), there were no significant volumetry errors:
20.3%67.9% and 21.3%69.4% for the radiologists and CAD,
Table 2. Interobserver agreement for all nodules.
between
radiologists
between radiologist
and CAD
mean
Kappa
mean
SE
mean
Kappa mean SE
100 mAs 120 kV 0.895 0.084 0.693 0.105
100 mAs 100 kV 0.908 0.087 0.641 0.113
100 mAs 80 kV 0.903 0.093 0.696 0.081
50 mAs 120 kV 0.881 0.069 0.528* 0.113
50 mAs 100 kV 0.853 0.073 0.481* 0.115
50 mAs 80 kV 0.880 0.070 0.518* 0.114
25 mAs 120 kV 0.898 0.068 0.592 0.125
25 mAs 100 kV 0.864 0.080 0.721 0.110
25 mAs 80 kV 0.801* 0.091 0.526* 0.127
Note - SE, standard error; mAs, Miliampe`resecond; kVp, Kilovolt peek; CAD,
computer assisted detection.
*significant: p,0.05; compared to standard CT.
doi:10.1371/journal.pone.0082919.t002
Figure 2. Dose dependent sensitivity for solid nodules and subjective image quality. The sensitivity of radiologists increased between 5
and 11% when CAD was used in combination with human assessment. When the dose was reduced, the subjective image quality dropped faster than
the sensitivity, i.e., an accurate diagnosis could be made even when the subjective image quality was reduced.
doi:10.1371/journal.pone.0082919.g002
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respectively. The SD was highest at the lowest dose level: 9.2%
and 15.6% for diameter and volume measurement differences,
respectively. The volume measurement SD proved to be highly
significant (,0.001), which means that there is a higher volatility
in the measurement errors without a significant difference in the
mean measurement. The per-diameter analysis at the standard
dose level demonstrated non-significantly higher measurement
errors for the radiologists in measuring the 5-mm nodules
(9.3%66.8%) compared to the other nodules (from 21% to
+1.9%). These data were accompanied by a higher volume
measurement error (Appendix S3). In absolute figures, the 5-mm
nodules were overestimated by 0.5 mm60.3 mm, which was not
significant. At the lowest dose level, the measurement error of all
nodules was between 21.3% and +5.3% for the diameter and
between 29.8% and +6.7% for the volume; neither error was
significant. In contrast, the CAD demonstrated significant
measurement errors for larger nodules at higher dose levels
(Table 4): the diameters of the 10- and 12-mm nodules were
overestimated by 0.6 and 1.2 mm, corresponding to a volume
measurement error between 36.6 and 60.2 mm3. There were no
significant measurement errors for the 5- and 8-mm nodules or
any nodules examined at the lower dose levels (25 and 50 mAs).
Discussion
This study demonstrated the feasibility of a low-dose CT when
both current and voltage are reduced together. The decrease in
the combined sensitivity for detecting solid nodules was only
significantly decreased at the lowest dose (25 mAs/80 kVp), which
was primarily due to the significant decrease in sensitivity for
detecting the solid 5-mm nodules at the lowest dose level. The
sensitivity for detecting all other nodules did not decrease
significantly at any dose level. The sensitivity threshold level of
significance for the per diameter analysis was low because the
number of nodules in each of the 8 categories was lower than in
the combined analysis. Therefore, a dose reduction from
100 mAs/120 kVp to 25 mAs/100 kVp seems possible, equaling
a reduction of the dose-length-product from 184 to 41 mGycm (a
78% dose reduction). At the second lowest dose level, no
significant loss in sensitivity was demonstrated for any nodule
size, nodule type, radiologist or combination of radiologist and
CAD. These results are consistent with studies that focused on
reducing either tube current or voltage separately [2,3,13,35].
Rusinek et al. reported an acceptable tube current level of 20 mAs
[35]. In previous studies, the advantage of reducing the CT tube
voltage to 80 kVp was mainly assessed to increase contrast on CT
angiography, especially to detect pulmonary embolisms [14–17].
Our results indicated that while a voltage level of 80 kVp was
sufficient for detecting solid nodules, a minimum of 100 kVp was
necessary to accurately detect GGNs. At all tube current levels, the
sensitivity decreased when the voltage was 80 kVp. This finding
supported the hypothesis that voltage has a greater impact on
sensitivity than low tube current. These results suggest that the
lowest CT tube parameters with acceptable image and diagnostic
quality for cancer screening are 25 mAs and 100 kVp. However,
as this was only a simulation, it will be necessary to conduct clinical
studies to confirm this dose level.
A low kV theoretically leads to an increase in contrast, with a
potentially improved detectability for GGNs; however, our data
comparing the 25 mAs/100 kVp versus the 50 mAs/80 kVp dose
levels did not support this theory. There is also doubt that this dose
change might improve the sensitivity for solid nodules because the
contrast is always very high (black and white) for lung nodule
recognition in a lung window setting. The main difficulty
encountered when detecting lung nodules is separating the nodules
from the vessels, which is likely limited by the image noise.
Interestingly, the sensitivity for detecting GGNs was higher than
the sensitivity for detecting solid nodules at almost all dose levels.
One likely reason for this difference is that there is an absence of
areas with ground glass opacities in the phantom lung, which
consisted of either black lung (air) or white lung (broncho-vascular
tree and artificial solid nodules), therefore making it easier to
detect structures with different attenuation, such as artificial
GGNs.
When the dose level was decreased from the standard to the
lowest dose, the subjective image quality dropped from 5 to 2.75,
while the average sensitivity decreased by only 10%. This result
confirmed the hypothesis that excellent image quality is not
necessary for nodule or pattern detection [2–13].
The feasibility of detecting nodules with low-dose CAD was
demonstrated in an earlier study [24]. In this study, CAD
performed equally well at tube currents of 5 mAs and 75 mAs with
a CT voltage level of 120 kVp. We additionally showed that CAD
was able to detect solid nodules at a voltage level of 80 kVp. CAD
was significantly inferior in detecting GGNs: CAD achieved a
maximum sensitivity of only 59.1% at the standard CT dose
compared to the 94.9% sensitivity achieved by the radiologists.
Moreover, the CAD sensitivity for GGN detection dropped to
20.6% at the lowest dose. CAD demonstrated significant lower
sensitivities for smaller GGNs at lower doses. This observation is in
accordance with the manufacturer’s statement (MEDIAN) that the
detection performance of the LMS CAD is optimized for solid
pulmonary nodules. This result may present a serious problem in
clinical detection because lung adenocarcinomas often appear as
GGNs [36,37]. Further studies are needed to investigate other
CAD brands to confirm these results.
In our study, the radiologists’ capacity to detect solid nodules at
the standard dose levels could be significantly improved by 5.1%
using CAD. Previous investigators have also stated the usefulness
of CAD [18–20,38], with reports of between 5 and 20% increased
sensitivity [19,20]. In these studies, the radiologists’ sensitivity for
solid nodule detection was closer to 60% than 100% without
CAD, which meant that there was greater room for improvement
when CAD was added. The impact of CAD on the radiologists’
sensitivity was even greater at lower dose levels. In our study, the
sensitivity increased up to 11.1% at the lowest dose (25 mAs/
100 kVp), which was likely due to the lower starting point of the
sensitivity at lower dose levels. Because the capacity of CAD to
detect GGNs was low, there was also a small impact on the
sensitivity of detecting GGNs when CAD was combined with the
radiologists’ findings (between 0% and 4.2%). Unexpectedly, the
false-positive rates of the CAD decreased at lower dose levels and
depicted mostly branching vessels.
Inter-observer variability among radiologists was greater than
the agreement between CAD and the human eye; this difference
demonstrated the capacity of the CAD to contribute additional
accuracy in nodule detection. The best clinical scenario would be
one in which high sensitivities for both the radiologists and CAD
were combined with a poor agreement, which would lead to a
maximum combined detection rate. The sensitivity of CAD
divided by the K strength of agreement could be a new indicator
for CAD accuracy. If CAD were used in place of a radiologist as
the second reader, the greatest impact would be on the sensitivity
of detecting solid nodules. Although the addition of CAD resulted
in improved sensitivity, there were also more false positives, which
negatively impacted the specificity. However, the use of CAD also
helped to overcome the loss of image quality at lower dose levels. If
the dose is lowered to 25 mAs/100 kVp, the addition of CAD can
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Table 4. RECIST-diameter- and volume-measuremet-errors of CAD for each nodule size and dose level.
RECIST VOLUME
5 mm nodules
mean
(mm) sd ME sd ME% sd
mean
(mm3) sd VME sd VME% sd
100 mAs 120 kV 5.3 0.7 0.3 0.7 6.2% 14.2% 75.3 17.3 9.9 17.3 15.1% 26.5%
100 mAs 100 kV 5.1 0.4 0.1 0.4 1.3% 7.8% 69.4 13.6 4.0 13.6 6.1% 20.7%
100 mAs 80 kV 5.1 0.6 0.1 0.6 2.4% 11.8% 73.1 11.9 7.7 11.9 11.7% 18.2%
50 mAs 120 kV 4.8 0.4 20.2 0.4 23.9% 8.7% 68.7 10.1 3.2 10.1 4.9% 15.4%
50 mAs 100 kV 4.9 0.7 20.1 0.7 22.1% 14.4% 67.8 5.8 2.3 5.8 3.5% 8.8%
50 mAs 80 kV 4.7 0.3 20.3 0.3 26.8% 5.9% 64.3 7.0 21.2 7.0 21.8% 10.7%
25 mAs 120 kV 4.8 0.2 20.2 0.2 23.2% 3.5% 71.5 7.2 6.1 7.2 9.2% 11.1%
25 mAs 100 kV 4.7 0.3 20.3 0.3 25.8% 5.7% 66.5 6.6 1.1 6.6 1.6% 10.1%
25 mAs 80 kV 4.7 0.2 20.3 0.2 25.3% 4.9% 64.2 4.3 21.3 4.3 21.9% 6.6%
8 mm nodules mm sd ME sd ME% sd Vol sd VME sd VME% sd
100 mAs 120 kV 8.3 0.4 0.3 0.4 4.1% 4.7% 277.8 10.4 9.8 10.4 3.6% 3.9%
100 mAs 100 kV 8.2 0.3 0.2 0.3 3.0% 3.5% 273.7 10.3 5.6 10.3 2.1% 3.8%
100 mAs 80 kV 8.3 0.4 0.3 0.4 3.6% 4.8% 278.5 11.8 10.4 11.8 3.9% 4.4%
50 mAs 120 kV 7.9 0.2 20.1 0.2 21.1% 2.4% 270.8 11.4 2.7 11.4 1.0% 4.2%
50 mAs 100 kV 7.9 0.3 20.1 0.3 21.3% 4.2% 273.2 10.2 5.1 10.2 1.9% 3.8%
50 mAs 80 kV 7.9 0.2 20.1 0.2 21.5% 1.9% 257.8 10.6 210.2 10.6 23.8% 4.0%
25 mAs 120 kV 7.9 0.2 20.1 0.2 21.5% 3.1% 271.2 11.0 3.1 11.0 1.2% 4.1%
25 mAs 100 kV 7.9 0.4 20.1 0.4 21.0% 4.7% 260.4 20.5 27.7 20.5 22.9% 7.6%
25 mAs 80 kV 7.6 0.4 20.4 0.4 24.7% 4.9% 227.4 41.8 240.7 41.8 215.2% 15.6%
10 mm nodules mm sd ME sd ME% sd Vol sd VME sd VME% sd
100 mAs 120 kV 10.6 0.1 0.6* 0.1 5.8%* 1.3% 570.8 14.4 47.2* 14.4 9.0%* 2.7%
100 mAs 100 kV 10.6 0.3 0.6* 0.3 5.6%* 2.7% 564.8 16.5 41.2* 16.5 7.9%* 3.2%
100 mAs 80 kV 10.5 0.3 0.5* 0.3 5.4%* 2.6% 560.2 15.6 36.6* 15.6 7.0%* 3.0%
50 mAs 120 kV 10.1 0.3 0.1 0.3 1.2% 3.3% 549.7 15.9 26.1 15.9 5.0% 3.0%
50 mAs 100 kV 9.9 0.4 20.1 0.4 20.8% 3.6% 539.9 25.7 16.3 25.7 3.1% 4.9%
50 mAs 80 kV 10.0 0.2 0.0 3.1 211.4% 31.3% 520.9 23.0 22.7 65.1 20.5% 31.5%
25 mAs 120 kV 10.2 0.7 0.2 0.7 1.6% 6.9% 565.9 151.0 42.3 151.0 8.1% 28.8%
25 mAs 100 kV 10.3 0.8 0.3 0.8 3.3% 7.8% 555.8 144.8 32.2 144.8 6.2% 27.7%
25 mAs 80 kV 10.1 0.7 0.1 0.7 1.1% 7.3% 572.7 151.1 49.1 151.1 9.4% 28.8%
12 mm nodules mm sd ME sd ME% sd Vol sd VME sd VME% sd
100 mAs 120 kV 12.9 0.7 0.9 0.7 7.5% 5.4% 958.7 32.8 53.9* 20.8 6.0%* 2.4%
100 mAs 100 kV 13.0 0.5 1.0 0.5 7.9% 4.5% 966.3 24.3 61.5* 24.3 6.8%* 2.7%
100 mAs 80 kV 13.2 0.5 1.2* 0.5 10%* 4.3% 965.0 21.0 60.2* 21.0 6.7%* 2.3%
50 mAs 120 kV 12.0 0.2 0.0 0.2 20.2% 1.5% 941.3 19.1 36.5 19.1 4.0% 2.1%
50 mAs 100 kV 12.1 0.3 0.1 0.3 0.8% 2.5% 904.5 27.1 20.3 27.1 0.0% 3.0%
50 mAs 80 kV 12.0 0.3 0.0 0.3 20.4% 2.2% 851.5 113.1 253.3 113.1 25.9% 12.5%
25 mAs 120 kV 12.3 0.2 0.3 0.2 2.8% 1.7% 924.8 28.5 20.0 28.5 2.2% 3.2%
25 mAs 100 kV 12.2 0.2 0.2 0.2 1.3% 1.9% 895.3 9.5 29.5 9.5 21.1% 1.0%
25 mAs 80 kV 12.2 0.3 0.2 0.3 1.3% 2.2% 876.6 37.8 228.2 37.8 23.1% 4.2%
Note-ME: measurement error, sd: standard deviation, ME%: ME in percent of longest diameter, VME: volume measurement error,
VME%: VME in percent of nodule volume.
*Significant measurement errors.
doi:10.1371/journal.pone.0082919.t004
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improve the sensitivity of solid nodule detection to 97.7%, which is
higher than the sensitivity of human readers on standard CT
without CAD (89.7%). It is important to note that these results are
valid for phantoms and may not be applicable to a smoker’s lung.
Clinical prospective studies are needed to address this issue.
We could not document a significant VME for any dose level in
the combined nodule analysis for the radiologists or the semi-
automated CAD. The VME for the radiologists was
3.8%611.7%, which was lower than the 13.7%616.8% VME
for CAD. The overestimation of the nodule volume was not
significant with either method. The per-nodule diameter analysis
confirmed this finding for CAD and larger nodules. At higher dose
levels, larger nodules were significantly overestimated. Xie et al.
[25] reported volume underestimations of 26.4%6 15.5% and
7.6%6 8.5% for radiologists and semi-automated CAD, respec-
tively. In addition, Willemink et al. reported volume underesti-
mations ranging from –0.9% to –23.9% for a semi-automatic
volume measurement software at comparable low-dose levels with
nodules $5 mm [39]. In addition to the use of a different image
reconstruction kernel and slice thickness, another plausible reason
for this discordance may be differences in computers’ nodule
border detection algorithms (segmentations). From the radiolo-
gist’s perspective, nodule measurement is likely experience-
dependent. While beginners tend to include the full thickness of
the ground glass transition zone around the nodule into the
measurement, more experienced radiologists measure from the
middle to the middle transmission zone. The variance in the
volume measurement differences at the standard CT dose was
significantly lower than the variance of the lowest CT dose, which
indicates higher fluctuation and volatility of the measurement
differences at lower dose levels without significant differences in
the mean measurements for both the radiologists and the CAD.
Limitations
This study is an anthropomorphic phantom study, and our
results need to be confirmed in a clinical setting. In particular, the
BMI of our phantom, which is based on an average Japanese
male, is likely lower than the BMI of the average western white
male; therefore, the investigated dose levels resulted in lower
image noise levels, which may have positively influenced the
sensitivity.
In addition, this study was conducted using a CT scanner
equipped with filtered back-projection image reconstruction.
Further research is likely necessary to find the lowest dose levels
with iterative image reconstruction in lung nodule detection.
We did not investigate the dependency of nodule location on
sensitivity; however, the high number and random placement of
nodules permitted a realistic simulation. Another limitation is that
only spherical lesions were used, which is certainly not the typical
shape of a malignant nodule; therefore, it may have been more
difficult to detect round nodules surrounded by round-to-ovoid
vessels. Irregular lesions may be prone to higher variances/
measurement errors as scan parameters are changed. In addition,
the HU value of the solid nodules was higher (100 HU) than most
‘human’ solid nodules. Moreover, the density of ‘lung tissue’ in the
phantom is below normal, as there is no tissue in the phantom.
This factor may lead to an overestimation of the sensitivity.
We did not focus on specificity in our study setting. A true
negative would be defined as a negative phantom; however, the
study was designed for nodules and not for phantoms. Further-
more, although specificity is important, it is secondary in a study
that primarily addresses screening.
Conclusion
Radiologists’ sensitivity for detecting solid lung nodules (86–
90%) was only impaired when the tube current and voltage were
both decreased to 25 mAs/80 kVp (81%). Independent of the
tube current, the sensitivity for detecting GGNs was significantly
lower at all dose levels at 80 kVp. The CAD and the radiologists
had similar sensitivities for detecting solid nodules; however, the
CAD had a lower sensitivity for detecting GGNs when used as a
standalone device. The CAD significantly increased the radiolo-
gists’ sensitivity for detecting solid nodules at all dose levels (5–
11%). Based on our results, a low-dose CT protocol using 25 mAs
and 100 kVp with conventional filtered back-projection image
reconstruction is an acceptable method for detecting nodules in an
anthropomorphic lung phantom.
Supporting Information
Appendix S1 Sensitivities of individual readers with and
without CAD for each exposure level.
(XLSX)
Appendix S2 CAD sensitivities per nodule diameter for
each exposure level.
(XLSX)
Appendix S3 RECIST-Diameter- and Volume-measure-
ment-errors of radiologist for each nodule size.
(XLSX)
Author Contributions
Conceived and designed the experiments: AC ZSF JER. Performed the
experiments: AC AH PS LL LE. Analyzed the data: AC LE. Contributed
reagents/materials/analysis tools: JH. Wrote the paper: AC LE.
References
1. Yu L, Liu X, Leng S, Kofler JM, Ramirez-Giraldo JC, et al. (2009) Radiation
dose reduction in computed tomography: techniques and future perspective.
Imaging Med 1: 65–84.
2. Christe A, Torrente JC, Lin M, Yen A, Hallett R, et al. (2011) CT screening and
follow-up of lung nodules: effects of tube current-time setting and nodule size
and density on detectability and of tube current-time setting on apparent size.
AJR Am J Roentgenol 197: 623–630.
3. Christe A, Lin MC, Yen AC, Hallett RL, Roychoudhury K, et al. (2012) CT
patterns of fungal pulmonary infections of the lung: comparison of standard-dose
and simulated low-dose CT. Eur J Radiol 81: 2860–2866.
4. Michel JL, Reynier C, Avy G, Bard JJ, Gabrillargues D, et al. (2001) [An
assessment of low-dose high resolution CT in the detection of benign asbestos-
related pleural abnormalities]. J Radiol 82: 922–923.
5. Zompatori M, Fasano L, Mazzoli M, Sciascia N, Cavina M, et al. (2002) Spiral
CT evaluation of pulmonary emphysema using a low-dose technique. Radiol
Med 104: 13–24.
6. Yamada T, Ono S, Tsuboi M, Saito H, Sato A, et al. (2004) Low-dose CT of the
thorax in cancer follow-up. Eur J Radiol 51: 169–174.
7. Yi CA, Lee KS, Kim TS, Han D, Sung YM, et al. (2003) Multidetector CT of
bronchiectasis: effect of radiation dose on image quality. AJR Am J Roentgenol
181: 501–505.
8. Rizzi EB, Schinina V, Gentile FP, Bibbolino C (2007) Reduced computed
tomography radiation dose in HIV-related pneumonia: effect on diagnostic
image quality. Clin Imaging 31: 178–184.
9. Tack D, De Maertelaer V, Petit W, Scillia P, Muller P, et al. (2005) Multi-
detector row CT pulmonary angiography: comparison of standard-dose and
simulated low-dose techniques. Radiology 236: 318–325.
10. Bankier AA, Schaefer-Prokop C, De Maertelaer V, Tack D, Jaksch P, et al.
(2007) Air trapping: comparison of standard-dose and simulated low-dose thin-
section CT techniques. Radiology 242: 898–906.
11. Das M, Muhlenbruch G, Heinen S, Mahnken AH, Salganicoff M, et al. (2008)
Performance evaluation of a computer-aided detection algorithm for solid
Optimal Dose Levels for Lung Cancer Screening CT
PLOS ONE | www.plosone.org 10 December 2013 | Volume 8 | Issue 12 | e82919
pulmonary nodules in low-dose and standard-dose MDCT chest examinations
and its influence on radiologists. Br J Radiol 81: 841–847.
12. Paul NS, Siewerdsen JH, Patsios D, Chung TB (2007) Investigating the low-dose
limits of multidetector CT in lung nodule surveillance. Med Phys 34: 3587–
3595.
13. Christe A, Charimo-Torrente J, Roychoudhury K, Vock P, Roos JE (2013)
Accuracy of low-dose computed tomography (CT) for detecting and character-
izing the most common CT-patterns of pulmonary disease. Eur J Radiol 82:
e142–150.
14. Szucs-Farkas Z, Schibler F, Cullmann J, Torrente JC, Patak MA, et al. (2011)
Diagnostic accuracy of pulmonary CT angiography at low tube voltage:
intraindividual comparison of a normal-dose protocol at 120 kVp and a low-
dose protocol at 80 kVp using reduced amount of contrast medium in a
simulation study. AJR Am J Roentgenol 197: W852–859.
15. Holmquist F, Nyman U (2006) Eighty-peak kilovoltage 16-channel multidetector
computed tomography and reduced contrast-medium doses tailored to body
weight to diagnose pulmonary embolism in azotaemic patients. Eur Radiol 16:
1165–1176.
16. Thomas CK, Muhlenbruch G, Wildberger JE, Hohl C, Das M, et al. (2006)
Coronary artery calcium scoring with multislice computed tomography: in vitro
assessment of a low tube voltage protocol. Invest Radiol 41: 668–673.
17. Schueller-Weidekamm C, Schaefer-Prokop CM, Weber M, Herold CJ, Prokop
M (2006) CT angiography of pulmonary arteries to detect pulmonary embolism:
improvement of vascular enhancement with low kilovoltage settings. Radiology
241: 899–907.
18. White CS, Pugatch R, Koonce T, Rust SW, Dharaiya E (2008) Lung nodule
CAD software as a second reader: a multicenter study. Acad Radiol 15: 326–
333.
19. Roos JE, Paik D, Olsen D, Liu EG, Chow LC, et al. (2010) Computer-aided
detection (CAD) of lung nodules in CT scans: radiologist performance and
reading time with incremental CAD assistance. Eur Radiol 20: 549–557.
20. Das M, Muhlenbruch G, Mahnken AH, Flohr TG, Gundel L, et al. (2006) Small
pulmonary nodules: effect of two computer-aided detection systems on
radiologist performance. Radiology 241: 564–571.
21. Li F, Arimura H, Suzuki K, Shiraishi J, Li Q, et al. (2005) Computer-aided
detection of peripheral lung cancers missed at CT: ROC analyses without and
with localization. Radiology 237: 684–690.
22. Armato SG, 3rd, Li F, Giger ML, MacMahon H, Sone S, et al. (2002) Lung
cancer: performance of automated lung nodule detection applied to cancers
missed in a CT screening program. Radiology 225: 685–692.
23. Lee JW, Goo JM, Lee HJ, Kim JH, Kim S, et al. (2004) The potential
contribution of a computer-aided detection system for lung nodule detection in
multidetector row computed tomography. Invest Radiol 39: 649–655.
24. Hein PA, Rogalla P, Klessen C, Lembcke A, Romano VC (2009) Computer-
aided pulmonary nodule detection - performance of two CAD systems at
different CT dose levels. Rofo 181: 1056–1064.
25. Xie X, Zhao Y, Snijder RA, van Ooijen PM, de Jong PA, et al. (2013) Sensitivity
and accuracy of volumetry of pulmonary nodules on low-dose 16- and 64-row
multi-detector CT: an anthropomorphic phantom study. Eur Radiol 23: 139–
147.
26. Aroua A, Besancon A, Buchillier-Decka I, Trueb P, Valley JF, et al. (2004) Adult
reference levels in diagnostic and interventional radiology for temporary use in
Switzerland. Radiat Prot Dosimetry 111: 289–295.
27. Bongartz G, Golding SJ, Jurik AG (2004) ‘‘European Guidelines for Multislice
Computed Tomography,’’ Funded by the European Commission; Contract
number FIGM-CT2000–20078-CT-TIP.
28. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, et al. (2000)
New guidelines to evaluate the response to treatment in solid tumors. European
Organization for Research and Treatment of Cancer, National Cancer Institute
of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:
205–216.
29. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, et al. (2009)
New response evaluation criteria in solid tumours: revised RECIST guideline
(version 1.1). Eur J Cancer 45: 228–247.
30. Goldman RN, Weinberg JS (1985) Statistics: an introduction Englewood Cliffs,
NJ: Prentice Hall. pp. 334–353.
31. Zar JH (2010) Biostatistical analysis, 5th edition, Pearson Prentice-Hall, Upper
Saddle River, NJ. pp. 543–555.
32. Fleiss JL (1971) Measuring nominal scale agreement among many raters.
Psychol Bull 76: 378–83.
33. Fleiss JL (1981) Statistical methods for rates and proportions. 2nd edition, John
Wiley, New York. pp. 38–46.
34. Landis JR, Koch GG (1977) The measurement of observer agreement for
categorical data. Biometrics 33: 159–174.
35. Rusinek H, Naidich DP, McGuinness G, Leitman BS, McCauley DI, et al.
(1998) Pulmonary nodule detection: low-dose versus conventional CT.
Radiology 209: 243–249.
36. Godoy MC, Naidich DP (2009) Subsolid pulmonary nodules and the spectrum
of peripheral adenocarcinomas of the lung: recommended interim guidelines for
assessment and management. Radiology 253: 606–622.
37. Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM, Pistolesi M, et
al. (2013) Recommendations for the management of subsolid pulmonary nodules
detected at CT: a statement from the Fleischner Society. Radiology 266: 304–
317.
38. Awai K, Murao K, Ozawa A, Komi M, Hayakawa H, et al. (2004) Pulmonary
nodules at chest CT: effect of computer-aided diagnosis on radiologists’
detection performance. Radiology 230: 347–352.
39. Willemink MJ, Leiner T, Budde RP, de Kort FP, Vliegenthart R, et al. (2012)
Systematic error in lung nodule volumetry: effect of iterative reconstruction
versus filtered back projection at different CT parameters. AJR Am J Roentgenol
199: 1241–1246.
Optimal Dose Levels for Lung Cancer Screening CT
PLOS ONE | www.plosone.org 11 December 2013 | Volume 8 | Issue 12 | e82919
